# Advancements in longevity and healthspan research

> Live situation record from CLSTR: https://clstr.news/situations/advancements-in-longevity-and-healthspan-research
> Updated: 2026-08-27T07:00:00.000Z. Sources: 6. Developments: 2.

Scientific research into longevity is increasingly focusing on the concept of ‘healthspan’—maximizing the period of functional, healthy life—rather than solely extending total lifespan. 

Initial developments include the use of ‘network medicine’ by researchers at Northeastern University and Harvard to identify FDA-approved drugs that may slow biological aging by analyzing protein interactions. This computational approach aims to map how drug targets relate to aging-related gene clusters like mitochondrial dysfunction.

Subsequent developments highlight the role of artificial intelligence in analyzing genomic datasets to accelerate research into gene therapy, cellular reprogramming, and senolytic therapies. While medical progress has increased survival rates for certain conditions like cardiovascular disease, research continues to emphasize the compression of morbidity through preventative advancements.

## Claims

- Researchers from the Max Planck Institute for Demographic Research and Karolinska Institute analyzed Swedish health records from 1987 to 2022. (single source)
- The study examined health data for individuals born between 1904 and 1960. (single source)
- The global longevity market is projected to surpass $600 billion by 2030. (single source)
- Artificial intelligence is accelerating longevity research by analyzing genomic datasets and predicting drug repurposing. (single source)

## Timeline

### 2026-08-27: Longevity science shifts focus from lifespan to healthspan

Longevity science is evolving to prioritize healthspan over lifespan, utilizing AI and senolytic therapies to treat aging as a modifiable biological process, with a market projected to exceed $600 billion.

4 sources. https://clstr.news/cluster/longevity-science-shifts-focus-from-lifespan-to-healthspan

### 2026-08-23: Researchers use network medicine to identify drugs that may slow aging

Scientists are using network medicine to identify FDA-approved drugs that could slow aging, while experts advocate shifting focus from extending lifespan to maximizing healthy healthspan.

3 sources. https://clstr.news/cluster/researchers-use-network-medicine-to-identify-drugs-that-may-slow-aging

---
Cite as: Advancements in longevity and healthspan research. CLSTR, https://clstr.news/situations/advancements-in-longevity-and-healthspan-research